Form 8-K - Current report:
SEC Accession No. 0001193125-19-067302
Filing Date
2019-03-07
Accepted
2019-03-07 16:35:32
Documents
6
Period of Report
2019-03-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d720057d8k.htm 8-K 21927
2 EX-4.1 d720057dex41.htm EX-4.1 57829
3 EX-4.2 d720057dex42.htm EX-4.2 59569
4 EX-4.3 d720057dex43.htm EX-4.3 60106
5 EX-4.4 d720057dex44.htm EX-4.4 58885
6 EX-5.1 d720057dex51.htm EX-5.1 6244
  Complete submission text file 0001193125-19-067302.txt   265813
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 19666316
SIC: 2834 Pharmaceutical Preparations